Neostigmine Methylsulfate Injection
Product Images NDC 71872-7271

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 71872-7271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7271.jpg (7271)

This is a description of Neostigmine Methylsulfate Injection, USP. It is a 10mg/10mL solution contained in a multiple-dose vial for intravenous use. It contains neostigmine methylsulfate, phenol, sodium acetate trihydrate, and water. The solution is pH adjusted with sodium hydroxide/acetic acid. It should be stored in a cool, dry place and protected from light until use. The package insert contains directions for use. This injection is manufactured by Capin Serlss Limited and distributed by Medical Purchasing Solutions. It is used in medical treatments.*

FDA Label Image

Neos.jpg (Neos)

This is a product description for Neostigmine Methylsulfate Injection USP used for intravenous use. The injection comes in a 10 mL multiple dose vial with a concentration of 10 mg/10 mL. It is manufactured by Somerset Therapeutics and contains phenol as a preservative. It also contains sodium acetate tritydrate and water for injection. The directions for use can be found in the package insert. It should be stored at 20°C to 25°C (68°F to 77°F) and protected from light. The product code is TNDrugs/TNO003457.*

FDA Label Image

Neostigmine1 (Neostigmine1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.